(SRNE) Lead Plaintiff Alert: Does Your Loss Exceed $100,000 In Sorrento Therapeutics? Contact Johnson Fistel, LLP

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

(SRNE) Lead Plaintiff Alert: Does Your Loss Exceed $100,000 In Sorrento Therapeutics? Contact Johnson Fistel, LLP

PR Newswire

SAN DIEGO, May 29, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has been filed on behalf of all those who purchased or otherwise, acquired Sorrento Therapeutics, Inc. ("Sorrento" or the "Company") (NASDAQ: SRNE) between May 15, 2020 and May 22, 2020, inclusive (the "Class Period"). 

The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or otherwise acquired Sorrento securities during the Class Period to seek appointment as lead plaintiff.  A lead plaintiff acts on behalf of all other class members in directing the litigation.  The lead plaintiff can select a law firm of its choice.  An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.  If you wish to serve as lead plaintiff, you must move the Court no later July 27, 2020.  If you want to discuss this action or have any questions concerning this notice, please contact Jim Baker ([email protected]) at 619-814-4471.  If emailing, please include a phone number. 

According to the Complaint, the Company made false and misleading statements to the market. It failed to disclose: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and lacked a reasonable basis.

Plaintiff seeks to recover damages on behalf of all those who purchased or otherwise acquired Sorrento securities during the Class Period. 

If your losses are more than $100,000 and you are interested in your rights and options, or if you are interested in seeking to be a lead plaintiff, please [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/srne-lead-plaintiff-alert-does-your-loss-exceed-100-000-in-sorrento-therapeutics-contact-johnson-fistel-llp-301067789.html

SOURCE Johnson Fistel, LLP

Copyright CNW Group 2020

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).